1. Apyx One console approved for commercial launch in South Korea. 2. Initial orders expected to start shipping in Q4 2025. 3. South Korea's cosmetic surgery market projected to grow from $1.7B to $3.9B. 4. Renuvion technology targets post-weight-loss skin solutions for patients. 5. Seoul recognized as a global leader in cosmetic surgery and medical tourism.